{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:45:06Z","timestamp":1788396306889,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/IN\/Indo-US\/Foldscope\/39\/2015"],"award-info":[{"award-number":["BT\/IN\/Indo-US\/Foldscope\/39\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.retram.2026.103585","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:07:41Z","timestamp":1775027261000},"page":"103585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role of IGF2BP3 as a prognostic biomarker in chronic myeloid leukemia progression and disease stratification"],"prefix":"10.1016","volume":"74","author":[{"given":"Pragati","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Ubaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kashif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra Prasad","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6483-0802","authenticated-orcid":false,"given":"Vivek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0001","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s13287-021-02659-1","article-title":"Chronic myeloid leukemia stem cells: targeting therapeutic implications","volume":"12","author":"Mojtahedi","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0002","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.retram.2026.103585_bib0003","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41375-023-01822-2","article-title":"Management of children and adolescents with chronic myeloid leukemia in blast phase: international pediatric CML expert panel recommendations","volume":"37","author":"Sembill","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0004","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","article-title":"Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomark Res"},{"issue":"15","key":"10.1016\/j.retram.2026.103585_bib0006","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1158\/1078-0432.CCR-17-2602","article-title":"Insulin-like growth factor 2 mRNA-binding protein 3 is a novel post-transcriptional regulator of Ewing Sarcoma malignancy","volume":"24","author":"Mancarella","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.retram.2026.103585_bib0007","doi-asserted-by":"crossref","first-page":"996","DOI":"10.5306\/wjco.v11.i12.996","article-title":"Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia","volume":"11","author":"Stuckey","year":"2020","journal-title":"World J Clin Oncol"},{"issue":"2","key":"10.1016\/j.retram.2026.103585_bib0008","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability","volume":"54","author":"Zhang","year":"2022","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0009","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1038\/s41467-024-51634-w","article-title":"IGF2BP3 promotes mRNA degradation through internal m7G modification","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"issue":"Pt 3","key":"10.1016\/j.retram.2026.103585_bib0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","article-title":"The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer","volume":"86","author":"Ramesh-Kumar","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"10.1016\/j.retram.2026.103585_bib0011","first-page":"2273","article-title":"New patterns of genetic instability in chronic myeloid leukemia: interesting, but not ready for clinical use","volume":"108","author":"Schiffer","year":"2023","journal-title":"Haematologica"},{"issue":"11","key":"10.1016\/j.retram.2026.103585_bib0012","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1002\/mco2.787","article-title":"RNA modification in normal hematopoiesis and hematologic malignancies","volume":"5","author":"Chen","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.retram.2026.103585_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-8722-6-54","article-title":"Biomarkers for determining the prognosis in chronic myelogenous leukemia","volume":"6","author":"Sweet","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.retram.2026.103585_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.eswa.2023.121186","article-title":"Can ChatGPT provide intelligent diagnoses? A comparative study between predictive models and ChatGPT to define a new medical diagnostic bot","volume":"235","author":"Caruccio","year":"2024","journal-title":"Expert Syst Appl"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0015","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1186\/s12909-023-04698-z","article-title":"Revolutionizing healthcare: the role of artificial intelligence in clinical practice","volume":"23","author":"Alowais","year":"2023","journal-title":"BMC Med Educ"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0016","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision medicine, AI, and the future of personalized health care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin Transl Sci"},{"issue":"2","key":"10.1016\/j.retram.2026.103585_bib0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/bdcc7020062","article-title":"The role of ChatGPT in data science: how AI-assisted conversational interfaces are revolutionizing the field","volume":"7","author":"Hassani","year":"2023","journal-title":"Big Data Cogn Comput"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41698-024-00733-4","article-title":"Large language model use in clinical oncology","volume":"8","author":"Carl","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"17","key":"10.1016\/j.retram.2026.103585_bib0019","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1073\/pnas.0802047105","article-title":"Notch signaling mediates hypoxia-induced tumor cell migration and invasion","volume":"105","author":"Sahlgren","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.retram.2026.103585_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110569","article-title":"Genome-wide identification and analysis of prognostic features in human cancers","volume":"38","author":"Smith","year":"2022","journal-title":"Cell Rep"},{"issue":"21","key":"10.1016\/j.retram.2026.103585_bib0021","first-page":"3615","article-title":"An overview of myeloid blast-phase chronic myeloid leukemia","volume":"16","author":"Pamuk","year":"2024","journal-title":"Canc"},{"issue":"1","key":"10.1016\/j.retram.2026.103585_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.6004\/jnccn.2024.0007","article-title":"Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","volume":"22","author":"Shah","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.retram.2026.103585_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.912942","article-title":"The molecular role of HIF1\u03b1 is elucidated in chronic myeloid leukemia","volume":"12","author":"Singh","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.retram.2026.103585_bib0024","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2024-204473","article-title":"Novel small molecule inhibitor against IGF2BP3 with potent anti-leukemic activity","volume":"144","author":"Jaiswal","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2026.103585_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/bloodadvances.2023011132","article-title":"Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia","volume":"8","author":"Lin","year":"2024","journal-title":"Blood Adv"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318626000218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:56:09Z","timestamp":1781888169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318626000218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2452318626000218"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2026.103585","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of IGF2BP3 as a prognostic biomarker in chronic myeloid leukemia progression and disease stratification","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2026.103585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103585"}}